SILVERARC CAPITAL MANAGEMENT, LLC – Intra-Cellular Therapies, Inc. Transaction History
SILVERARC CAPITAL MANAGEMENT, LLC portfolio value:
$6.33M
portfolio value
SILVERARC CAPITAL MANAGEMENT, LLC quarter portfolio value change:
-18.48%
quarter
Intra-Cellular Therapies, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -56.64% | -177.83K shares | -11.58M | $46.53 | 136.12K |
| Q2 2022 | share | Increase | +1.67% | 5.14K shares | -976K | $57.08 | 313.96K |
| Q1 2022 | share | Increase | +58.37% | 113.81K shares | 8.69M | $61.19 | 308.81K |
| Q4 2021 | share | Increase | +91.38% | 93.11K shares | 6.40M | $52.13 | 195K |
| Q3 2021 | share | Decrease | -10.04% | -11.36K shares | -825K | $37.28 | 101.89K |
| Q2 2021 | share | Decrease | -12.96% | -16.85K shares | 208K | $40.82 | 113.25K |
| Q1 2021 | share | Decrease | -34.94% | -69.88K shares | -1.94M | $33.93 | 130.11K |
| Q4 2020 | share | Increase | 0.00% | 200K shares | 6.36M | $31.8 | 200K |